You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《新股消息》傳瑞信、中金及高盛加入微醫上市團隊 料上半年在港上市籌20-30億美元
阿思達克 03-02 15:50
據路透旗下IFR報道,騰訊(00700.HK)有份投資的微醫據今年在港上市,籌20-30億美元,消息人士指公司計劃將瑞信、中金及高盛加入其團隊,並與招銀國際、花旗及摩通合作,料交易最快今年上半年完成。

據悉微醫尋求估值達150億美元,受惠疫情帶動需求,公司去年收入增長三倍,而逾半收入是訂閱形式,其數碼化長期病管理服務人均收入高達3,600元人民幣,去年訂戶人數已達13.5萬人。報道指公司尋求上市前估值達120億美元,而上市後估值則達150億美元,並將發售15-20%的股權。(el/k) ~

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account